VI INTERNATIONAL MEETING Atrial fibrillation 2005 Atrial fibrillation and heart failure: the ugly and the nasty Bologna - Italy, Palazzo Re Enzo SEPTEMBER 18-19-20, 2005 FINAL PROGRAM PRESIDENT Alessandro Capucci (Piacenza, Italy) EUROPEAN SOCIETY OF CARDIOLOGY
VI INTERNAT I O NAL MEETING Atrial fibrillation 2005 Atrial fibrillation and heart failure : the ugly and the nasty B ologna - Ital y, Palazzo Re Enzo S EP TE MBER 1 8-19-20, 20 05 MEETING ORGANISED IN COLLABORATION with the European Heart Rhythm Association a registered branch of the European Society of Cardiology CHAIRMAN S. Priori (Pavia, Italy) NUCLEUS MEMBERS C. Blomström-Lundqvist (Uppsala, Sweden) M. Borggrefe (Münster, Germany) C. Linde (Stockholm, Sweden) P.E. Vardas (Heraklion, Greece) PRESIDENT A. Capucci Division of Cardiology, Ospedale Guglielmo da Saliceto Via Taverna, 49 29100 Piacenza PC, Italy Phone: +39 0523 303215 Fax: +39 0523 303228 e-mail: progettovita@hotmail.com
FACULTY AUSPICES AIAC Associazione Italiana di Aritmologia e Cardiostimolazione ANMCO Associazione Nazionale Medici Cardiologi Ospedalieri ANCE Associazione Nazionale Cardiologi Extraospedalieri Hearth Rhythm Society SIC Società Italiana di Cardiologia Assessorato alla Sanità della Regione Emilia Romagna Università degli Studi di Bologna European Heart Rhythm Association ORGANIZING SECRETARIAT STUDIO E.R. CONGRESSI GRUPPO TRIUMPH Via G. Marconi, 36-40122 Bologna BO, Italy Phone: +39 051 4210559 - Fax: +39 051 4210174 e-mail: ercongressi@gruppotriumph.it www.ercongressi.it PRESS OFFICE ANGELS Srl Aura Nobolo Via Cola Di Rienzo, 271-00192 Roma Phone: +39 06 3225611 - Fax: +39 06 32646504 e-mail: auranobolo@hotmail.com 2
FACULTY M. Adamo Bologna, Italy P. Adragão Lisbon, Portugal M. Allessie Maastricht, The Netherlands M. Baroni Bologna, Italy A. Bianchi Milano, Italy M. Biffi Bologna, Italy C. Blomström-Lundqvist Uppsala, Sweden G. Botto Como, Italy M. Brignole Lavagna, Italy R. Cappato Milano, Italy A. Capucci Piacenza, Italy S.A. Chen Taipei, Taiwan S.J. Connolly Hamilton, Canada H.J.G.M. Crijns Maastricht, The Netherlands A. Del Rosso Fucecchio, Italy A. Di Lenarda Trieste, Italy M. Eldar Tel Hashomer, Israel C. Fabris Mestre, Italy R. Ferrari Ferrara, Italy F. Gaita Asti, Italy P. Giannuzzi Veruno, Italy U. Guiducci Reggio Emilia, Italy Y. Ho London, UK S.H. Hohnloser Frankfurt, Germany D. Igidbashian Gorizia, Italy C.W. Israel Frankfurt, Germany E.A. Jankowska Wroclaw, Poland M.J. Janse Amsterdam, The Netherlands L. Jordaens Rotterdam, The Netherlands J. Kautzner Prague, Czech Republic K.H. Kuck Hamburg, Germany E. Labriola Bologna, Italy S. Lévy Marseille, France G. Lip Birmingham, UK B. Lüderitz Bonn, Germany M. Mantica Milano, Italy L. Marinelli San Marino, RSM N. Marrazzo Mercogliano, Italy N. Marrouche Salt Lake City, USA G. Mascioli Brescia, Italy A.S. Montenero Sesto San Giovanni, Italy A. Mugelli Firenze, Italy G.V. Naccarelli Hershey, USA 3
FACULTY A. Natale Cleveland, USA S. Nattel Montreal, Canada P. Nocerino Benevento, Italy E. Occhetta Novara, Italy S.B. Olsson Lund, Sweden L. Padeletti Firenze, Italy G. Perego Milano, Italy M. Piepoli Piacenza, Italy A. Puglisi Roma, Italy R. Quaglione Roma, Italy G. Quirino Ivrea, Italy A. Raviele Mestre, Italy A. Sagone Milano, Italy M. Santini Roma, Italy G. Senatore Ciriè, Italy S. Sermasi Rimini, Italy N. Sulke Eastbourne, UK C. Tondo Milano, Italy A. van Oosterom Lausanne, Switzerland P.E. Vardas Heraklion, Greece R. Verlato Camposampiero, Italy A. Vincenti Monza, Italy L. Zamparelli Napoli, Italy 4
SUNDAY 18, 2005 14.00 REGISTRATION DESK OPEN 16.00 Symposium ANCE Heart Failure and Atrial Fibrillation: Out of Hospital treatment Chairmen: M. Adamo, M. Baroni 16.00-16.20 Epidemiology and clinical correlations C. Fabris 16.20-16.40 The role of the adrenergic nervous system and the renin-angiotensin system A. Bianchi 16.40-17.00 Therapeutical strategies M. Baroni 17.00-17.20 Antithrombotic therapy: old and new drugs E. Labriola 17.20-17.40 New non-pharmacological options M. Biffi 17.40-18.00 DISCUSSION 18.15 Opening Ceremony and Welcome Cocktail 5
MONDAY 19, 2005 08.00 REGISTRATION DESK OPEN 08.45 Open Remarks 09.00 Symposium Atrial Fibrillation and Heart Failure: a pathophysiologic link Chairmen: S. Nattel, A. van Oosterom 09.00-09.20 Cardiac Morphology and AF: basic mechanism or target to therapy? Y. Ho 09.20-09.40 Mechanisms of AF in heart failure M.J. Janse 09.40-10.00 Clinical relevance of differencies between atrial and ventricular remodelling in congestive heart failure S. Nattel 10.00-10.20 Molecular and mechanical influences of AF on HF A. Mugelli 10.20-10.40 Silent AF and its clinical implication S.H. Hohnloser 10.40 COFFEE BREAK 11.00 Symposium Co-morbidities in AF and HF Chairmen: U. Guiducci, J. Kautzner 11.00-11.20 Renal disfunction E.A. Jankowska 11.20-11.40 AF chronic haemodialisis A. Vincenti 11.40-12.00 Chronic obstructive pulmonary disease P. Giannuzzi 6
MONDAY 19, 2005 12.00-12.20 Diabetics A. Di Lenarda 12.20-12.40 Sleep disorder breathing M. Eldar 12.40-13.00 Exercise intolerance M. Piepoli 13.00-13.30 Ronald Campbell Lecture: Diagnosis of the Electro-Pathological Substrate of AF M. Allessie 13.30-15.00 LUNCHEON PANELS m Salone del Podestà Luncheon Panel Guidant The Clinical Spectrum of AF in Heart Failure: Physiopatology, Population and Treatment m Sala di Re Enzo Luncheon Panel Vitatron Atrial Fibrillation: When, Where and How to Pace the Heart? 15.00-16.40 Sala di Re Enzo ABSTRACT SESSION Chairmen: S. Sermasi, L. Zamparelli 15.00 Symposium Medical Treatment Chairmen: C. Blomström-Lundqvist, B. Lüderitz 15.00-15.20 Is it necessary to modify the guidelines after AFFIRM? B. Lüderitz 15.20-15.40 How AF is being treated in Europe H.G.J.M. Crijns 15.40-16.00 Is Amiodarone the first line treatment? P.E. Vardas 7
MONDAY 19, 2005 16.00-16.20 The BIFAC trial and its clinical implications A. Capucci 16.20-16.40 Treating HF and preventing AF J. Kautzner 16.40-17.00 Targeting new goals R. Ferrari 17.00 DISCUSSION 8
TUESDAY 20, 2005 08.00 REGISTRATION DESK OPEN 08.30 Symposium Pacing and alternatives Chairmen: L. Jordaens, M. Santini 08.30-08.50 Site or algorythm L. Padeletti 08.50-09.10 Does anti AF pacing actually work to improve patient symptoms? N. Sulke 09.10-09.30 Biventricular pacing in HF: also for AF? C.W. Israel 09.30-09.50 AVN ablation and BV pacing: is the panacea? M. Brignole 09.50-10.10 The Atrial Defibrillator today M. Santini 10.10-10.30 COFFEE BREAK 10.30 Symposium Anticoagulation and AF: new concept to follow Chairmen: P. Adragão, S.J. Connolly 10.30-10.50 Pathogenesis of Thromboembolism in AF: VIRCHOW s triad G. Lip 10.50-11.10 Oral thrombin inhibition will change the therapeutical attitude S.B. Olsson 11.10-11.30 Active trial and clinical consequences S.J. Connolly 11.30 Symposium AF: new concepts with clinical implication Chairmen: L. Marinelli, G.V. Naccarelli 11.30-11.50 A new model of AF: from theory to practice A. van Oosterom 11.50-12.10 Loop recorder and atrial fibrillation: toll or toy? A.S. Montenero 9
TUESDAY 20, 2005 12.10-12.30 The new era of antiarrhythmic drugs G.V. Naccarelli 12.45-14.30 LUNCHEON PANELS m Salone del Podestà Luncheon Panel Medtronic New Terapeutical Approaches and New Technologies in Heart Failure m Sala di Re Enzo Luncheon Panel Biotronik Seda Advance in treatment of cardiac arrhythmia 14.45 Symposium Ablate or not ablate Chairmen: K.H. Kuck, S. Lévy 14.45-15.05 PV ablation revisited after ten years experience A. Natale 15.05-15.25 3D imaging for ablation of AF: useful or mandatory? N. Marrouche 15.25-15.45 Eco-guided RF ablation: longlasting results? A. Raviele 15.45-16.05 The role of permanent PV isolation K.H. Kuck 16.05-16.25 The 3 steps approach R. Cappato 16.25-16.45 How to manage the complications of the ablation procedures S.A. Chen 16.45-17.05 Surgical Ablation: back to the scene F. Gaita 17.05 DISCUSSION AND CONCLUSIONS 10
LUNCHEON PANELS Luncheon Panel Guidant Monday 19, 2005 13.30 15.00 SALONE DEL PODESTÀ The Clinical Spectrum of AF in Heart Failure: Physiopatology, Population and Treatment Chairmen: P. Adragão, M. Santini Is Atrial Fibrillation a Consequence or a Cause of Heart Failure? M. Allessie What Clinical impact does Atrial Fibrillation have on this population of Patients? And how big is this Population? G. Botto What is the best Pharmacological Treatment for Patients with Heart Failure and Atrial Fibrillation? R. Ferrari CRT in Patients with Atrial Fibrillation : what have we learned from the latest Clinical Trials: Companion, SCD-HEft, Care HF M. Mantica Which is the role of a CRT-D implantable device with Atrial Therapies, for Electrical Treatment of Heart Failure patients with Atrial Fibrillation? L. Padeletti Luncheon Panel Vitatron SALA DI RE ENZO Atrial Fibrillation: When, Where and How to Pace the Heart? Chairmen: D. Igidbashian, A. Puglisi Atrial fibrillation and right ventricular apical pacing in Patients with SSS A. Del Rosso Where to pace the right ventricle in patients with AV block? P. Nocerino The diagnosis of silent atrial fibrillation G. Quirino How to pace the atrium for atrial fibrillation prevention? The EPASS study R. Verlato 11
LU NCHEON PANELS Luncheon Panel Medtronic Tuesday 20, 2005 12.45 14.30 SALONE DEL PODESTÀ New Terapeutical Approaches And New Technologies In Heart Failure Chairmen: A.S. Montenero, C. Tondo CRT patients with AF management: which strategies and which clinical outcomes? N. Marrazzo Selection of the vessels for CRT G. Senatore ATP therapies in heart failure patients: rationale and outcomes G. Mascioli Fluid monitoring and early treatment of HF recurrences G. Perego Permanent Hissian pacing: a new physiological pacing mode E. Occhetta Luncheon Panel Biotronik Seda SALA DI RE ENZO Advance in treatment of cardiac arrhythmia Chairmen: D. Igidbashian, A. Vincenti Atrial fibrillation monitoring in pacemaker patients: how Home Monitoring can help us to early detect and better manage it? tbd Discussion Which benefits could we achieve using Closed Loop Stimulation in patients with atrial arrhythmias? A. Sagone Discussion Developments on treatment of brady-tachy syndrome through the physiological pacing R. Quaglione Discussion 12
ABSTRACT SESSI ON Monday 19, 2005 15.00 16.40 Abstract Session Chairmen: S. Sermasi, L. Zamparelli SALA DI RE ENZO Transseptal Approach for Left Atrial Arrhythmia Ablation in Patients with Mitral Valve Prosthesis Barbato G., Pergolini F., Carinci V., Di Pasquale G. (Bologna Italy) New 8 mm Tip Catheter with 4 Thermocouple Sensors and Basket 31 mm Mapping System for Ablation of Atrial Fibrillation Barbato G., Pergolini F., Carinci V., Favaro A.,Casanova M., Di Pasquale G. (Bologna Italy, Boston Scientific) Sleep Apnoea and Atrial Fibrillation in Patients with Sinus Bradycardia Diotallevi P., Pieragnoli P., Ravazzi P., Gostoli E., Baldi N., Russo V., Orazi S., Occhetta E., Di Biase L., Padeletti L. (Alessandria, Firenze, Taranto, Rieti, Novara Italy) The Predictive Value of 6 Weeks Monitoring for the Further Development of Atrial Fibrillation: The Role of Pacemaker Diagnostics Lewalter T.H., Leonhardt V., Russo V, Klomps H.C., Svetlich C., Pauletti M., Magliari F., Reis H., Lamparelli R. (Bonn, Berlin Germany, Taranto Italy, Weert - The Netherlands, Lucca, Livorno, Lecce Italy, Porto - Portugal, Johannesburg- South Africa) Atrial Fibrillation: Evaluation of Hospital Consultations/Hospitalizations/Costs at the Operative Unit in Sassuolo Melandri F., Fontana P.L., Gazzotti L., Agnoletto V., Bagni E., Bellesi P., Accietto C., Magnavacchi P. (Modena, Sassuolo Italy) Pharmacologic Conversion of Atrial Fibrillation in Patients with Normal or Borderline Systolic Function: Amiodarone vs. Propafenone, with Quinidine as a Reserve Option Milicevic G., Pazur V., Frank B., Komadina M., Urek R., Tomicic D. (Croatia) Plasma BNP Levels Predict Atrial Fibrillation after Cardiac Surgery Sarzi Braga S., Vaninetti R., Peraro M., Masnaghetti S., Pedretti R.F.E. (Tradate - Italy) Clinical Experience on a Cohort of Consecutive Patients Implanted for Symptomatic Sinus Bradycardia: progression and Newly Documented Atrial Fibrillation Bignotti M., Barbieri D., Onofri M., Turri E., Venturini D. (Tradate, Bologna Italy, Vitatron Medical Italia) Suboptimal guideline adherence in heart failure management among atrial fibrillation patients Nieuwlaat R., Crijins H.G.J.M. (Maastricht The Netherlands) 13
THANKS TO Guidant St. Jude Medical Biotronik Seda Medtronic Vitatron Ela Medical Johnson & Johnson Sanofi-Aventis 3M AstraZeneca Bristol-Myers Squibb GE Healthcare Medico Merk Sharp & Dohme Sigma Tau Sorin Biomedica CRM 14
GENERAL INFORMATION MEETING VENUE Palazzo Re Enzo Piazza Maggiore - Bologna Italy Located in the centre of Bologna on one of the most beautiful squares in the world, Palazzo Re Enzo combines the majestic beauty and fascinating of an ancient building with the best in modern facilities. Palazzo Re Enzo was built in 1200 to house the Bologna Curia. Down the centuries it has been a seat of justice under the City State, the residence of the podestà, or city governor and of the Captain of the People. It takes its name, Re Enzo, from the medieval king who was imprisoned there from 1249 to 1271. Enzo, King of Sardinia, the natural son of Federick II of Sicily, was captured by the Bolognese at the battle of Fossalta. He was kept in the fortress until his death in 1271. The story goes that his imprisonment was worthy of a king, however, and that Enzo spent many pleasant hours in the company of nobles reading poetry and enjoying the finer things of life. After his death, the palace was given his name in honour of its illustrious guest. PALAZZO RE ENZO PLAN First floor Salone del Podestà Reception Organizing Secretariat Press Office Exhibition Area and coffee point: Sala degli Atti Slide Center Second floor Sala di Re Enzo Distance to the Railway station: km 0,5 Distance to the Airport: km 13 Public parking: Piazza VIII Agosto (walking distance) Parking Staveco (Bus A for the city centre) 15
GENERAL I NFORM ATI ON SCIENTIFIC SECRETARIAT Alessandro Capucci Division of Cardiology Ospedale Guglielmo da Saliceto Via Taverna, 49 29100 Piacenza PC Italy Phone +39-0523-303215 Fax +39-0523-303228 e-mail: progettovita@hotmail.com ORGANIZING SECRETARIAT Studio E.R. Congressi Gruppo Triumph Via Marconi, 36 40122 Bologna BO - Italy Phone +39-051-4210559 Fax +39-051-4210174 E-mail ercongressi@gruppotriumph.it www.ercongressi.it OFFICIAL LANGUAGE English. REGISTRATION FEES (in Euro VAT included) a 500,00 The registration fee includes: participation in all the scientific sessions, welcome cocktail, luncheon panels, access to the exhibition area, proceedings book, attendance certificate, coffee-breaks. 16
GENERAL INFORMATION REGISTRATION The conference is open to all duly registered participants. The official participant name badge is required for admission to all conference events. Registration desk: the registration desk is located on ground floor, in front of the main entrance. Registration hours: Sunday 18 from 14.00 to 19.00 Monday 19 from 8.00 to 18.00 Tuesday 20, from 8.00 to 18.00 Registrations can only be accepted and confirmed when the registration form and fee have been received by the Organizing Secretariat, Studio E.R. Congressi. All payments must be done in Euro net of all bank charges and made out to Studio E.R. Congressi srl. Payment should be done by: m Eurocheque or Foreign Cheque m Bank Transfer made out to Studio E.R.Congressi srl Account n. 000000002596 Cassa di Risparmio di Cesena, Agenzia n.29, L.go Caduti del Lavoro 1/A - 40122 Bologna - Italy ABI 06120 - CAB 02400 - Swift code CECRIT 2C IBAN IT36J CIN J m Credit Card Please send a copy of the bank transfer with the registration form. TRAVEL AGENCY BONONIAVIAGGI BT & I Piazza dei Martiri 1-40122 Bologna - Italy Phone +39-051-4211585 Fax +39-051-249846 busim@bononiaviaggi.it 17
GENERAL I NFORM ATI ON HOTEL RESERVATION Categories and special prices C a t e g o ry SINGLE DOUBLE SINGLE USE DOUBLE min max min max min max 4 stars a 160,00 a 190,00 a 180,00 a 220,00 3 stars a 100,00 a 120,00 a 115,00 a 150,00 a 120,00 a 170,00 These prices are per night and per room and include bed and breakfast and taxes. The amount of a 20,00 has to be added as agency reservation fee. Hotel reservation can only be accepted and confirmed when the form and the confirmatory deposit (the price of one night per room in the selected hotel category, plus a 20,00 for agency rights) have been received by Bononia Viaggi. Payment should be done by: m Eurocheque or Foreign Cheque m Bank Transfer made out to Bononia Viaggi Srl Account n. 9000/2 - ABI 6385 - CAB 02418 SWIFT CODE: CRBOITB Cassa di Risparmio di Bologna - Filiale S. Giuseppe, Via Saragozza 87 40135 Bologna Italy. m Credit Card Please send a copy of the bank transfer with the accommodation form. ABSTRACTS The presentation time for every oral communication is 7 minutes followed by 4 minutes for debate. PROCEEDINGS BOOK The proceedings book contains the texts of the interventions included in the Scientific Programme. It will be edited by CEPI Centro Editoriale Pubblicitario Italiano, and distributed to all registered members at the beginning of the Meeting as a part of the conference kit. All the accepted abstracts will be published. EXHIBITION AREA The exhibition area can be visited during the whole Meeting. The Technical and pharmaceutical exhibition will be located in Sala degli Atti. 18
GENERAL INFORMATION PRESS Accredited press operators can contact the press office. They will be given a press kit. PRESS OFFICE: Angels Srl Aura Nobolo - Via Cola di Rienzo, 271 00192 Roma Tel +39-06-3225611 Fax +39-06-32646504 e:mail: auranobolo@hotmail.com SLIDES Slides must be in english. Computer videoprojection will be available. Other requirements should be communicated to the Organizing Secretariat as soon as possible. Slides should be handed to the Slide Center one hour before the beginning of the session and collected at the end. The Organizers do not assume any liability for damage or loss of slides that have not been properly collected. LUNCH Lunches will be served during the luncheon panels, limited to seat availability. BADGE All registered participants, speakers and exhibitors, will be given a badge, which they must wear to be admitted to the scientific sessions. Badges have been color-coded as follows : m Blue: faculty m Yellow: participants m Red: exhibitors m White: staff ATTENDANCE CERTIFICATE A certificate will be given to all participants at the end of the meeting. ECM Accreditation has been requested for MDs. The Ministry of Health has given to the meeting 12 ECM credits. 19
GENERAL I NFORM ATI ON SECRETARIAT The conference secretariat will be open during the whole Meeting. Staff members will be happy to assist you for any further information you may require. INSURANCE Responsibility for personal accidents or loss or damage to the private property of participants cannot be accepted. Participants are advised to make their own arrangements, with respects to insurance, if they consider necessary. CURRENCY AND BANKING FACILITIES The unit of currency is Euro (a). Banks for money exchange and cheque cashing are located near the Meeting Venue. Bank offices are open from 8.20 to 13.20 and from 14.30 to 16.00 (Monday to Friday). LOST AND FOUND For any lost and found object, please contact the Registration desk. CHANGES Parts of the program may be changed by the Scientific Committee or by the Organizing Secretariat if necessary for scientific or technical reasons. 20
SCIENTIFIC SECRETARIAT Alessandro Capucci Division of Cardiology, Ospedale Guglielmo da Saliceto Via Taverna, 49-29100 Piacenza PC Italy Phone +39-0523-303215 Fax +39-0523-303228 e-mail: progettovita@hotmail.com ORGANIZING SECRETARIAT Studio E.R. Congressi Gruppo Triumph Via Marconi, 36-40122 Bologna BO - Italy Phone +39-051-4210559 Fax +39-051-4210174 E-mail ercongressi@gruppotriumph.it www.ercongressi.it